Table 3.
The chessboard procedure used to determine how well a multiplex test performs on samples containing >1 target.
| Pathogen 1 dilution series | Pathogen 2 dilution series |
||||||
|---|---|---|---|---|---|---|---|
| (a) 10−1 | (b) 10−2 | (c) 10−3 | (d) 10−4 | (e) 10−5 | (f) 10−6 | (g) 10−7 | |
| (A) 10−1 | Aa | Ab | Ac | Ad | Ae | Af | Ag |
| (B) 10−2 | Ba | Bb | Bc | Bd | Be | Bf | Bg |
| (C) 10−3 | Ca | Cb | Cc | Cd | Ce | Cf | Cg |
| (D) 10−4 | Da | Db | Dc | Dd | De | Df | Dg |
| (E) 10−5 | Ea | Eb | Ec | Ed | Ee | Ef | Eg |
| (F) 10−6 | Fa | Fb | Fc | Fd | Fe | Ff | Fg |
| (G) 10−7 | Ga | Gb | Gc | Gd | Ge | Gf | Gg |
| (H) 10−8 | Ha | Hb | Hc | Hd | He | Hf | Hg |
A dilution series of the extracted nucleic acid from pathogen 1 and pathogen 2 is made. Using a microtitre plate a volume of each dilution of pathogen 1 is added to each column so that, for example, dilution 1 of pathogen 1 (labelled here as (A)) is present in the first well of each column. Subsequently an equal volume of each dilution of pathogen 2 is added to each row so that, for example, dilution 1 of pathogen 2 (labelled here as (a)) is present in the first column only. The wells will now contain different concentrations of pathogens 1 and 2 and can be used to assess the multiplex PCR.